adjuvant pembrolizumab in kidney cancer from keynote 564
Published 5 months ago • 260 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
3:01
a phase iii trial of pembrolizumab as adjuvant treatment for renal cell carcinoma
-
17:46
gu asco 2024 highlights with dr. tian zhang – contact-02, brcaaway, ambassador, keynote-564
-
18:50
exploring the latest in renal cell cancer therapies with dr. monty pal using an algorithm
-
1:00
single agent vs combination in brca positive prostate cancer. #oncology
-
29:11
new data and clinical context: an update on renal cell carcinoma care
-
22:31
kidney cancer conference highlights from asco 2022
-
16:33
genitourinary cancer esmo 2022 highlights - oncbrothers (rohit & rahul gosain) w/ dr. toni choueiri
-
18:43
gu asco 2023 highlights - oncbrothers (rohit and rahul gosain) with dr. petros grivas
-
1:16
dr. gupta discusses adjuvant immunotherapy in kidney cancer
-
1:48
kidney cancer research supports immunotherapy | dana-farber cancer institute
-
1:08
incorporating immunotherapy in the frontline treatment of patients with bladder cancer
-
30:16
informed in 30: immunotherapy
-
2:00
the promise of cancer immunotherapy
-
2:38
the immunotherapy promise
-
2:25
keynote-224: second-line pembrolizumab for advanced hepatocellular carcinoma
-
4:56
cancer immunotherapy - explaining the science behind the revolution
-
7:19
pembrolizumab yielded durable responses in patients with advanced merkel cell carcinoma
-
2:09
new immunotherapy makes unresectable eye cancer treatable
-
31:46
the future of vaccine therapy in brain tumors: personalized immunotherapy - jerome graber, m.d., mph